COVID-19 and venous thromboembolism - prophylaxis and treatment

Reidar Kvåle; Nessar Ahmad Azrakhsh; Kristin Greve-Isdahl Mohn; Marianne Aanerud; Anne Berit Guttormsen; Håkon Reikvam

doi:10.4045/tidsskr.20.0440

COVID-19 and venous thromboembolism - prophylaxis and treatment

Tidsskr Nor Laegeforen. 2020 Jun 17;140(11). doi: 10.4045/tidsskr.20.0440. Print 2020 Aug 18.

[Article in English, Norwegian]

Authors

Reidar Kvåle, Nessar Ahmad Azrakhsh, Kristin Greve-Isdahl Mohn, Marianne Aanerud, Anne Berit Guttormsen, Håkon Reikvam

PMID: 32815357
DOI: 10.4045/tidsskr.20.0440

No abstract available

Plain language summary

As the pandemic has been unfolding, reports have emerged of a relatively high incidence of coagulopathy and thromboembolic events in connection with COVID-19 infections. Raised awareness surrounding this issue, and appropriate antithrombotic prophylaxis and treatment, are therefore important for this group of patients.

MeSH terms

Anticoagulants / therapeutic use
Betacoronavirus
COVID-19
Coronavirus Infections / complications*
Humans
Pandemics
Pneumonia, Viral / complications*
SARS-CoV-2
Venous Thromboembolism / prevention & control*
Venous Thromboembolism / therapy*

Substances

Anticoagulants